Nuclear Medicine Therapeutics Market Share

Statistics for the 2023 & 2024 Nuclear Medicine Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Nuclear Medicine Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Nuclear Medicine Therapeutics Industry

The nuclear medicine therapeutics market is primarily dominated by a few key players operating globally and regionally. These companies are well-known and hold significant market shares. The competitive landscape of the market includes an analysis of both international and local companies.

Some of the major players in the nuclear medicine therapeutics market include Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Fusion Pharmaceuticals, IBA Radiopharma Solutions, RadioMedix Inc., Telix Pharmaceuticals Ltd, NTP Radioisotopes, Bracco SpA, Cardinal Health Inc., Nordion Inc. (Sotera Health Company), and Triad Isotopes (Jubilant Life Sciences).

Nuclear Medicine Therapeutics Market Leaders

  1. IBA Radiopharma Solutions

  2. Bayer AG

  3. Alpha Tau Medical Ltd

  4. Actinium Pharmaceutical Inc.

  5. Jubilant Life Sciences Company

*Disclaimer: Major Players sorted in no particular order

Nuclear Medicine Therapeutics Market Concentration

Nuclear Medicine Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)